458 related articles for article (PubMed ID: 12542733)
21. Quantitative Evidence of Wear-Off Effect at the End of the Intravenous IgG (IVIG) Dosing Cycle in Primary Immunodeficiency.
Rojavin MA; Hubsch A; Lawo JP
J Clin Immunol; 2016 Apr; 36(3):210-9. PubMed ID: 26910102
[TBL] [Abstract][Full Text] [Related]
22. Intravenous immunoglobulins: evolution of commercial IVIG preparations.
Hooper JA
Immunol Allergy Clin North Am; 2008 Nov; 28(4):765-78, viii. PubMed ID: 18940573
[TBL] [Abstract][Full Text] [Related]
23. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.
Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R
Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura.
Robak T; Salama A; Kovaleva L; Vyhovska Y; Davies SV; Mazzucconi MG; Zenker O; Kiessling P;
Hematology; 2009 Aug; 14(4):227-36. PubMed ID: 19635187
[TBL] [Abstract][Full Text] [Related]
25. Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.
Blackhouse G; Xie F; Levine MA; Campbell K; Assasi N; Gaebel K; O'Reilly D; Tarride J; Goeree R
J Popul Ther Clin Pharmacol; 2012; 19(2):e166-78. PubMed ID: 22580389
[TBL] [Abstract][Full Text] [Related]
26. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
Erduran E; Aslan Y; Gedik Y; Orhan F
Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
[TBL] [Abstract][Full Text] [Related]
27. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura.
Hedlund-Treutiger I; Henter JI; Elinder G
J Pediatr Hematol Oncol; 2003 Feb; 25(2):139-44. PubMed ID: 12571466
[TBL] [Abstract][Full Text] [Related]
28. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience.
Alioglu B; Ercan S; Tapci AE; Zengin T; Yazarli E; Dallar Y
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649
[TBL] [Abstract][Full Text] [Related]
29. Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children.
Ancona KG; Parker RI; Atlas MP; Prakash D
J Pediatr Hematol Oncol; 2002 Oct; 24(7):540-4. PubMed ID: 12368690
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of IgPro20, a subcutaneous immunoglobulin, in Japanese patients with primary immunodeficiency diseases.
Kanegane H; Imai K; Yamada M; Takada H; Ariga T; Bexon M; Rojavin M; Hu W; Kobayashi M; Lawo JP; Nonoyama S; Hara T; Miyawaki T
J Clin Immunol; 2014 Feb; 34(2):204-11. PubMed ID: 24504846
[TBL] [Abstract][Full Text] [Related]
31. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.
Shahgholi E; Vosough P; Sotoudeh K; Arjomandi K; Ansari S; Salehi S; Faranoush M; Ehsani MA
Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials.
Qin YH; Zhou TB; Su LN; Lei FY; Zhao YJ; Huang WF
Blood Coagul Fibrinolysis; 2010 Dec; 21(8):713-21. PubMed ID: 20962624
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
[TBL] [Abstract][Full Text] [Related]
34. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
Tarantino MD; Madden RM; Fennewald DL; Patel CC; Bertolone SJ
J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia.
Robak T; Mainau C; Pyringer B; Chojnowski K; Warzocha K; Dmoszynska A; Straub J; Imbach P
Hematology; 2010 Oct; 15(5):351-9. PubMed ID: 20863431
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia.
Teeling JL; Jansen-Hendriks T; Kuijpers TW; de Haas M; van de Winkel JG; Hack CE; Bleeker WK
Blood; 2001 Aug; 98(4):1095-9. PubMed ID: 11493456
[TBL] [Abstract][Full Text] [Related]
37. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
Zeller MP; Heddle NM; Kelton JG; Hamilton K; Wang G; Sholapur N; Carruthers J; Hsia C; Blais N; Toltl L; Hamm C; Pearson MA; Arnold DM
Transfusion; 2016 Jan; 56(1):73-9. PubMed ID: 26400824
[TBL] [Abstract][Full Text] [Related]
38. Monitoring of two intravenous immunoglobulin. Preparations for immunoglobulin G subclasses and specific antibodies to bacterial surface antigens and relation with their levels in treated immunodeficient patients.
Lamari F; Karamanos NK; Papadopoulou-Alataki E; Kanakoudi-Tsakalidou F; Dimitracopoulos G; Anastassiou ED
J Pharm Biomed Anal; 2000 Jul; 22(6):1029-36. PubMed ID: 10857572
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency.
Wasserman RL; Church JA; Peter HH; Sleasman JW; Melamed I; Stein MR; Bichler J;
Eur J Pharm Sci; 2009 Jun; 37(3-4):272-8. PubMed ID: 19491015
[TBL] [Abstract][Full Text] [Related]
40. Randomized trial comparing intravenous immunoglobulin with methylprednisolone pulse therapy in acute idiopathic thrombocytopenic purpura. Danish I.T.P. Study Group.
Rosthøj S; Nielsen S; Pedersen FK
Acta Paediatr; 1996 Aug; 85(8):910-5. PubMed ID: 8863869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
